GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EOM Pharmaceutical Holdings Inc (OTCPK:IMUC) » Definitions » E10

EOM Pharmaceutical Holdings (EOM Pharmaceutical Holdings) E10 : $-9.36 (As of Jun. 2018)


View and export this data going back to 2006. Start your Free Trial

What is EOM Pharmaceutical Holdings E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

EOM Pharmaceutical Holdings's adjusted earnings per share data for the three months ended in Jun. 2018 was $-0.100. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-9.36 for the trailing ten years ended in Jun. 2018.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-22), EOM Pharmaceutical Holdings's current stock price is $0.16. EOM Pharmaceutical Holdings's E10 for the quarter that ended in Jun. 2018 was $-9.36. EOM Pharmaceutical Holdings's Shiller PE Ratio of today is .


EOM Pharmaceutical Holdings E10 Historical Data

The historical data trend for EOM Pharmaceutical Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EOM Pharmaceutical Holdings E10 Chart

EOM Pharmaceutical Holdings Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -12.40 -11.07

EOM Pharmaceutical Holdings Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.21 -11.27 -11.07 -9.50 -9.36

Competitive Comparison of EOM Pharmaceutical Holdings's E10

For the Biotechnology subindustry, EOM Pharmaceutical Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EOM Pharmaceutical Holdings's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EOM Pharmaceutical Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where EOM Pharmaceutical Holdings's Shiller PE Ratio falls into.



EOM Pharmaceutical Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, EOM Pharmaceutical Holdings's adjusted earnings per share data for the three months ended in Jun. 2018 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2018 (Change)*Current CPI (Jun. 2018)
=-0.1/106.3168*106.3168
=-0.100

Current CPI (Jun. 2018) = 106.3168.

EOM Pharmaceutical Holdings Quarterly Data

per share eps CPI Adj_EPS
200809 -16.000 92.307 -18.428
200812 -20.000 88.697 -23.973
200903 -20.000 89.744 -23.693
200906 -24.000 91.003 -28.039
200909 -12.000 91.120 -14.001
200912 -24.000 91.111 -28.005
201003 -20.000 91.821 -23.157
201006 -56.000 91.962 -64.741
201009 -24.000 92.162 -27.686
201012 -72.000 92.474 -82.778
201103 -45.378 94.283 -51.170
201106 -21.899 95.235 -24.447
201109 0.000 95.727 0.000
201112 -20.000 95.213 -22.332
201203 -84.000 96.783 -92.275
201206 -64.000 96.819 -70.278
201209 -8.000 97.633 -8.712
201212 12.000 96.871 13.170
201303 -40.000 98.209 -43.302
201306 -1.135 98.518 -1.225
201309 -28.000 98.790 -30.133
201312 4.000 98.326 4.325
201403 -20.000 99.695 -21.329
201406 -16.000 100.560 -16.916
201409 -12.454 100.428 -13.184
201412 -14.600 99.070 -15.668
201503 -8.000 99.621 -8.538
201506 -13.981 100.684 -14.763
201509 -16.000 100.392 -16.944
201512 -22.700 99.792 -24.184
201603 -24.700 100.470 -26.137
201606 -23.000 101.688 -24.047
201609 -15.800 101.861 -16.491
201612 -17.000 101.863 -17.743
201703 -16.700 102.862 -17.261
201706 -11.400 103.349 -11.727
201709 -4.000 104.136 -4.084
201712 -0.387 104.011 -0.396
201803 -0.245 105.290 -0.247
201806 -0.100 106.317 -0.100

Add all the adjusted EPS together and divide 10 will get our e10.


EOM Pharmaceutical Holdings  (OTCPK:IMUC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


EOM Pharmaceutical Holdings E10 Related Terms

Thank you for viewing the detailed overview of EOM Pharmaceutical Holdings's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


EOM Pharmaceutical Holdings (EOM Pharmaceutical Holdings) Business Description

Traded in Other Exchanges
N/A
Address
136 Summit Avenue, Suite 100, Montvale, NJ, USA, 07645
EOM Pharmaceutical Holdings Inc is focused on developing novel immunomodulatory and retinal disease drug agents to address a range of inflammatory, viral, retinal, and other diseases. Its product candidate includes dual-acting broad-spectrum immunomodulator EOM613, which has the potential to treat cancer cachexia and rheumatoid arthritis, and its advanced formulation of EOM147 is being studied to treat serious retinal diseases without the need for intraocular injection.
Executives
Andrew Gengos director 21900 BURBANK BOULEVARD, 3RD FLOOR, WOODLAND HILLS CA 91367
Gary Titus director, officer: Chairman and Secretary SCICLONE PHARMACEUTICALS, INC., 950 TOWER LANE, SUITE 900, FOSTER CITY CA 94404-2125
Anthony Gregg Lapointe director PO BOX 83216, GAITHERSBURG MD 20883-3216
Mark A Schlossberg director C/O IMPAX LABORATORIES, INC., 30831 HUNTWOOD AVENUE, HAYWARD CA 94544
Rahul Singhvi director 246 HOLLY DRIVE, CHALFONT PA 18914
Helen Susan Kim director 3832 BAY CENTER PLACE, HAYWARD CA 94545
Richard Chin director C/O OXIGENE, INC., 230 THIRD AVENUE, WALTHAM MA 02451
Richard Cowell director 7840 VIRGINIA OAK DRIVE, GAINSVILLE VA 20155
James G. Bender officer: VP, Product Development & Mfg. 112 WEST 34TH STREET, 17TH FLOOR, NEW YORK NY 10120
Manish Singh director, officer: President & CEO 21900 BURBANK BOULEVARD, 3RD FLOOR, WOODLAND HILLS CA 91367
Jacqueline Brandwynne director 649 STONE CANYON ROAD, LOS ANGELES CA 90077

EOM Pharmaceutical Holdings (EOM Pharmaceutical Holdings) Headlines